- 全部删除
您的购物车当前为空
Pramipexole (SND 919) 是能够透过血脑屏障的 D2 型多巴胺受体的选择性激动剂,对 D2 型受体、D2、D3、D4亚型受体的Ki 分别为 2.2 nM、3.9 nM、0.5 nM、1.3 nM。它可用于研究帕金森综合症和腿多动综合征。

Pramipexole (SND 919) 是能够透过血脑屏障的 D2 型多巴胺受体的选择性激动剂,对 D2 型受体、D2、D3、D4亚型受体的Ki 分别为 2.2 nM、3.9 nM、0.5 nM、1.3 nM。它可用于研究帕金森综合症和腿多动综合征。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 50 mg | ¥ 145 | In stock | |
| 100 mg | ¥ 192 | In stock | |
| 500 mg | ¥ 415 | In stock | |
| 1 g | ¥ 597 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 356 | In stock |
Pramipexole 相关产品
| 产品描述 | Pramipexole (SND 919) is a selective dopamine receptor agonist used in the therapy of Parkinson disease. Pramipexole therapy is associated with a low rate of transient serum enzyme elevations during treatment but has not been implicated in cases of clinically apparent acute liver injury. |
| 靶点活性 | D3 receptor:0.5 nM(Ki), D2S receptor:3.9 nM(Ki), D2L receptor:2.2 nM(Ki), D4 receptor:5.1 nM(Ki) |
| 别名 | 普拉克索, SND 919 |
| 分子量 | 211.33 |
| 分子式 | C10H17N3S |
| CAS No. | 104632-26-0 |
| Smiles | CCCN[C@H]1CCc2c(C1)sc(N)n2 |
| 密度 | 1.17 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 75 mg/mL (354.9 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) Ethanol: 39 mg/mL (184.55 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容